CA-125 in Screening Patients at High Risk for Ovarian Cancer

Withdrawn before enrolling

Conditions studied: Ovarian Cancer

In brief

RATIONALE: Measuring levels of CA 125 in blood samples of women who have a high risk of developing ovarian cancer may help doctors detect cancer early and plan more effective treatment. PURPOSE: This phase II trial is studying CA-125 levels in screening for cancer in women who are at high risk of developing ovarian cancer.

Key facts

Study ID

NCT00080639

Run by

University of Alabama at Birmingham

People needed

0

Starts

2003-06-01

Expected to finish

2007-06-01

Last updated by the study team

2013-08-05

Who can join

Age: 30 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Comprehensive Cancer Center at University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.